Yang W, Guo X, Lauand F, Li L, et al. Effects of age and disease duration on the efficacy and safety of iGlarLixi in Asian people with type 2 diabetes: A post hoc analysis of the LixiLan-O-AP and LixiLan-L-CN trials. Diabetes Obes Metab 2024 Jan 3. doi: 10.1111/dom.15414.
PMID: 38172083